New conditioning regimen with idarubicin and melphalan in autologous PBPC transplantation

被引：0
|
作者：
Musso, M
Porretto, F
Crescimanno, A
Bondi, F
Polizzi, V
Scalone, R
Cajozzo, A
Mariani, G
机构：
[1] Univ Palermo, Cattedra Ematol TMO, I-90133 Palermo, Italy
[2] Univ Palermo, Div Ematol TMO, I-90133 Palermo, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
342
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [1] Thiotepa and melphalan as a new conditioning regimen for autologous transplantation in multiple myeloma
    Grimaldi, F.
    Madonna, E.
    Avilia, S.
    Pane, F.
    Risitano, A. M.
    De Rosa, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S209 - S209
  • [2] Intense immunosuppressive conditioning regimen for autologous selected PBPC transplantation in severe autoimmune diseases
    Musso, M
    Porretto, F
    Crescimanno, A
    Bondi, F
    Polizzi, V
    Scalone, R
    BONE MARROW TRANSPLANTATION, 2001, 27 : S17 - S18
  • [3] High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors
    MA Diaz
    MG Vicent
    L Madero
    Bone Marrow Transplantation, 1999, 24 : 1157 - 1159
  • [4] High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors
    Diaz, MA
    Vicent, MG
    Madero, L
    BONE MARROW TRANSPLANTATION, 1999, 24 (11) : 1157 - 1159
  • [5] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
    Okay, M.
    Buyukasik, Y.
    Demiroglu, H.
    Malkan, U.
    Ciftciler, R.
    Aladag, E.
    Aksu, S.
    Haznedaroglu, I.
    Sayinalp, N.
    Ozcebe, O.
    Goker, H.
    LEUKEMIA RESEARCH, 2018, 73 : S27 - S27
  • [6] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
    Okay, Mufide
    Buyukasik, Yahya
    Demiroglu, Haluk
    Malkan, Umit Yavuz
    Ciftciler, Rafiye
    Aladag, Elifcan
    Aksu, Salih
    Haznedaroglu, Ibrahim Celalettin
    Sayinalp, Nilgun
    Ozcebe, Osman Ilhami
    Goker, Hakan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (04) : 985 - 992
  • [7] Autologous Stem Cell Transplantation with Moderate Dose of Idarubicin and Busulphan as Conditioning Regimen in Acute Myelogenous Leukemia
    Mashhadi, M. A.
    Ramzi, M.
    Alimoghaddam, K.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2008, 10 (03) : 202 - 207
  • [8] Busulfan or melphalan: is there a better conditioning regimen for allogeneneic transplantation?
    Hsu, Jingmei
    Van Besien, Koen
    Baron, Frederic
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1529 - 1534
  • [9] Bortezomib after high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with multiple myeloma: A comparison with the historical conditioning regimen with melphalan alone
    Ferini, G. A.
    Arbelbide, J. A.
    Basquiera, A. L.
    Nucifora, E.
    Schutz, N.
    Otero, V.
    Fantl, D.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S461 - S462
  • [10] High-dose idarubicin, busulphan and melphalan conditioning regimen for autograft in multiple myeloma
    Capria, S
    Petrucci, MT
    Ferrazza, G
    Ribersani, M
    Torromeo, C
    Trisolini, SM
    Mandelli, F
    Meloni, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S97 - S97
12345